Ticker HubNasdaq

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

Latest price

$0.3749+30.99%

As of Oct 28, 2026, 5:54 PM EDT · Market data by Massive

Market cap

$678.2K

Volume

14.4M

Previous close

$0.2862

Day range

$0.2529 – $0.2900

Listed

Apr 23, 2026

Coverage

0 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $0.4893Latest interval $0.3747

Newsroom

Latest LABT coverage

No matching articles yet.

Company overview

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Industry: PHARMACEUTICAL PREPARATIONS
Headquarters: UNIVERSITY PARK, FL
CIK: 0002079272

Company website View advanced chart

SEC filings

No filing records are attached to this profile yet.

Browse EDGAR

Profile at a glance

Apr 23, 2026

Listed

—

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.